Suncor Energy Declares Dividend
Get Alerts SU Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3.5%
EPS Growth %: +52.0%
Join SI Premium – FREE
All financial figures are in Canadian dollars.
Calgary, Alberta--(Newsfile Corp. - August 14, 2023) - Suncor Energy's (TSX: SU) (NYSE: SU) Board of Directors has approved a quarterly dividend of $0.52 per share on its common shares, payable Sept. 25, 2023 to shareholders of record at the close of business on Sept. 1, 2023.
Suncor Energy is Canada's leading integrated energy company. Suncor's operations include oil sands development, production and upgrading, offshore oil and gas production, petroleum refining in Canada and the U.S. and the company's Petro-Canada retail and wholesale distribution networks, including Canada's Electric Highway, a coast-to-coast network of fast-charging EV stations. Suncor is developing petroleum resources while advancing the transition to a low-emissions future through investment in power and renewable fuels. Suncor also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power. Suncor has been recognized for its performance and transparent reporting on the Dow Jones Sustainability North America Index, FTSE4Good Index and CDP. Suncor's common shares (symbol: SU) are listed on the Toronto and New York stock exchanges.
- 30 -
For more information about Suncor, visit our web site at suncor.com.
Media inquiries:
833-296-4570
[email protected]
Investor inquiries:
800-558-9071
[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/177220
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Scottie Resources Announces Closing of Second and Final Tranche of Non-Brokered Private Placement
- Who Is the Best Appraiser in Marin County? Top-Rated San Rafael Appraiser Austin Fernald Now Booking Home Appraisals Across Marin
- Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at ASN Kidney Week 2026
Create E-mail Alert Related Categories
Newsfile, Press ReleasesRelated Entities
Dividend, Crude OilSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share